As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.
“At this critical juncture, decisions about vaccine development, stockpiling, and deployment will shape our ability to respond to immediate and future pandemic risks,” write Jesse Goodman, MD, PhD; Rick A. Bright, PhD; and Nicole Lurie, MD, MSPH, in a JAMA Viewpoint published Sept. 4.
The current outbreak of H5N1 in North America has infected poultry, cows, wild birds, and marine and terrestrial mammals, along with at least 13 humans, primarily on dairy and poultry farms. No human-to-human transmission has been reported.
It is highly concerning that this H5N1 strain, compared with prior ones, has had unprecedented spread among mammals. Although human cases have so far been relatively mild, the threat of a pandemic is real, given the virus’s widespread and continued presence close to humans and its potential to reassort with human influenza viruses or mutate to acquire the ability to transmit among humans.”
Jesse Goodman, MD, PhD, Professor, Georgetown University
Goodman is a professor of medicine at Georgetown University School of Medicine and former FDA Chief Scientist; Bright is a principal with Bright Global Health and former Deputy Assistant Secretary for Preparedness and Response and the Director of the Biomedical Advanced Research and Development Authority (BARDA); and Lurie is executive director for Preparedness and Response at the Coalition for Epidemic Preparedness Innovations and Director of CEPI-US and former Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.
Focusing on vaccines, Goodman and his colleagues outline short, medium and long-term actions to combat the H5N1 risk: protect exposed individuals and reduce pandemic risk; refresh vaccine stockpiles and enhance capacity; lay the groundwork for mitigating future threats.
Short term
The authors note that the U.S. government is readying 4.8 million doses of stockpiled H5N8 vaccine, which is expected to offer cross-protection against current H5N1 strains.
As a short term consideration, the writers say, “Provided adequate supporting data and regulatory review, stockpiled vaccine(s) should be offered voluntarily to individuals at exposure risk.” Those at risk include farm workers with closure contact to animals.
Medium term
In the medium term, the authors stress the importance of ensuring that vaccine stockpiles are refreshed with doses well matched to circulating viruses. The goal is to ensure that at least 20 million individuals, particularly critical workforce members, can be rapidly immunized in the event of a pandemic.
In addition, the public health trio call for taking steps now to ready and enhance global pandemic influenza vaccine development and production capacity, including evaluating the potential of mRNA vaccines, which offer faster and more scalable manufacturing processes.
Long term
Looking further ahead, Goodman and his colleagues advocate for the exploration of pre-pandemic immunization strategies. This could involve vaccinating high-risk groups during interpandemic periods to build population immunity against potential pandemic strains, a strategy that, while unproven, could significantly mitigate the impact of future pandemics.
Finally, the authors call on elected officials, governments, global partners and the private sector to address H5N1 and other pandemic influenza threats through a comprehensive strategy for human and animal health encompassing pandemic vaccines as well as diagnostics, therapies, and non-pharmaceutical interventions. They note that the convergence of health and agricultural concerns, including protecting workers, farm animals, and the economy, presents an opportunity to transcend divides.
They conclude, “The time for decisive action is not when a pandemic strikes, but today, while we have the opportunity.”
Goodman, J. L., et al. (2024). H5 Influenza Vaccines—Moving Forward Against Pandemic Threats. JAMA. doi.org/doi:10.1001/jama.2024.17488

News
Specially engineered antibody delivers RNA therapy to treatment-resistant tumors
Elias Quijano, PhD; Diana Martinez-Saucedo, PhD; Zaira Ianniello, PhD; and Natasha Pinto-Medici, PhD, there are 25 other contributors, most from Yale's Department of Therapeutic Radiology and from the departments of genetics, molecular biophysics and [...]
Vaccinated women face fewer cervical cancer risks
New data from Denmark shows the HPV vaccine’s powerful long-term impact, while also revealing why cervical cancer screening is still essential. A Danish study published in the journal Eurosurveillance reports that women who received the human [...]
3D-printed implant offers a potential new route to repair spinal cord injuries
A research team at RCSI University of Medicine and Health Sciences has developed a 3-D printed implant to deliver electrical stimulation to injured areas of the spinal cord, offering a potential new route to [...]
Nanocrystals Carrying Radioisotopes Offer New Hope for Cancer Treatment
The Science Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for use in treating cancer. These crystals are smaller than many microbes and can carry isotopes of [...]
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]